Evidence map›Paper›PMID 41432978›Full record

ArticleJournal of cancer survivorship : research and practice2025

Understanding colorectal cancer-related stigma and its impact on cancer survivors in South-West Nigeria: a qualitative study of patients, caregivers, and healthcare professionals.

Catherine N Zivanov, Israel A Owoade, Erica J Mann, Oluwadayomi E Adedeji, Grace I Bassey, Oluwaleke J Fayenuwo, Titilope A Adeyanju, Christopher O Bamidele, Akintayo T Olaniyan, Adeoluwa O Adeleye and 15 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Catherine N ZivanovGlobal Cancer Research and Training Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. c.n.zivanov@wustl.edu.
Israel A OwoadeAfrican Research Group for Oncology, Ile-Ife, Osun State, Nigeria.
Erica J MannGlobal Cancer Research and Training Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Oluwadayomi E AdedejiAfrican Research Group for Oncology, Ile-Ife, Osun State, Nigeria.
Grace I BasseyDepartment of Surgery, University of Calabar Teaching Hospital, Calabar, Nigeria.
Oluwaleke J FayenuwoLittlemore Mental Health Centre, Sanford Road, Littlemore, Oxford, UK.
Titilope A AdeyanjuDepartment of Community Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
Christopher O BamideleAfrican Research Group for Oncology, Ile-Ife, Osun State, Nigeria.
Akintayo T OlaniyanAfrican Research Group for Oncology, Ile-Ife, Osun State, Nigeria.
Adeoluwa O AdeleyeAfrican Research Group for Oncology, Ile-Ife, Osun State, Nigeria.
Oluwabusayomi R AdemakinwaAfrican Research Group for Oncology, Ile-Ife, Osun State, Nigeria.
Adeyemi A AmudaDepartment of Community Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
Olaoti O OgundareDepartment of Community Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
H Dean HosgoodDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Rivka KahnGlobal Cancer Research and Training Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Cristina OlceseGlobal Cancer Research and Training Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Grace FitzgeraldGlobal Cancer Research and Training Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Olalekan OlasehindeDepartment of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.
Funmilola O WuraolaDepartment of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.
Tajudeen MohammedDepartment of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.
Matthew O BojuwoyeDepartment of Medicine, University of Ilorin, Kwara State, Ilorin, Nigeria.
Adewale AderounmuDepartment of Surgery, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria.
T Peter KinghamGlobal Cancer Research and Training Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Olusegun I AlatiseAfrican Research Group for Oncology, Ile-Ife, Osun State, Nigeria.
Adebola A AdedimejiDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeColorectal cancer-related stigma (CRC stigma) is understudied in a Nigerian context and likely contributes to delays in diagnosis and treatment. Understanding and addressing the drivers, manifestations, and impacts of CRC stigma can lead to improved survivorship outcomes. This study examined perceptions, attitudes, and behaviors related to CRC stigma in South-Western Nigeria to identify strategies for mitigating its consequences.

methodsBetween September 2022 and April 2023, 20 patients receiving treatment for CRC, 31 caregivers, and 16 healthcare professionals from Osun State, Nigeria, participated in 42 in-depth interviews and four focus group discussions about CRC perceptions and stigma. Qualitative content analysis was used to identify themes related to drivers, manifestations, and impacts of CRC stigma, as well as potential mitigating strategies.

resultsPerceived drivers of CRC stigma included cultural misperceptions about cancer and perceptibility of physical symptoms. Manifestations of CRC stigma were felt to disproportionately impact socioeconomically marginalized patients. Resultant social isolation, shame, mistrust, and delayed health-seeking behaviors, contributed to significant psychosocial burden and worse clinical outcomes. Although CRC stigma remains prevalent, participants noted a shift in community attitudes as CRC outcomes improve. Suggested strategies for mitigating CRC stigma included awareness campaigns, early diagnosis programs, patient and caregiver support programs, and resources for improved symptom management. CONCLUSIONS AND IMPLICATIONS FOR CANCER SURVIVORS: CRC stigma remains common in South-West Nigeria and contributes to worse oncologic outcomes and substantial psychosocial burden among patients with CRC. Interventions promoting early diagnosis and treatment, improved symptom management, and survivor empowerment may lessen the psychosocial impact of CRC stigma and improve long-term outcomes.

Indexed as

Cancer preventionCancer-related stigmaCancer screening and early diagnosisCancer survivorshipColorectal cancerLow- and middle-income countries

Identifiers

PMID41432978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.